EUVIMEDEUVIMED entdecken
Übersichtsarbeit

The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis

Jelena G Najdanović iD, Jelena M Živković, Stevo J Najman

Human Gene Therapy · 01.07.2026 · 37 (13-14) · 566-578

DOI: 10.1177/10430342261446500 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Human Gene Therapy, online erschienen am 14.05.2026. Verfasst von Jelena G Najdanović und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia. Hauptthemen laut MEDLINE: Osteopetrosis, Genetic Therapy, Cell- and Tissue-Based Therapy. Die Arbeit nennt 111 Literaturangaben. Gefördert von: Branch of SASA (Serbian Academy of Sciences and Arts) in Niš, Ministry of Education, Science and Technological Development of the Republic of Serbia.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Bone tissue represents a dynamic tissue that undergoes continuous renewal and remodeling through the coupled actions of osteoblast-driven bone formation and osteoclast-mediated bone resorption. Proper coupling between these two processes is essential for maintaining bone homeostasis, whereas its disruption leads to skeletal pathology. Excessive osteoclast activity underlies disorders such as osteoporosis and Paget’s disease, while osteoclast deficiency, either quantitative or functional, results in osteopetrosis. Osteopetrosis comprises a group of genetically heterogeneous and clinically variable rare metabolic bone diseases characterized by increased bone mass. Clinically, osteopetrosis is commonly classified into severe autosomal recessive osteopetrosis (ARO), also known as infantile malignant osteopetrosis, intermediate ARO, milder autosomal dominant osteopetrosis, and X-linked recessive osteopetrosis. Effective treatment options for both severe and milder forms of osteopetrosis remain an unresolved clinical challenge. This review sheds light on the potential of cell-based and gene-modified cell therapies as emerging strategies for the treatment of osteopetrosis. Current cell-based therapy approaches increasingly focus on induced pluripotent stem cells, while recent advances in gene therapy enable the correction of causative genetic defects through viral vector-mediated gene transfer, CRISPR/Cas9-based genome editing, or RNA interference-mediated gene silencing. In addition, the therapeutic potentials of immunological approaches based on recombinant human interferon gamma-1b is discussed. Despite significant progress, sustained research efforts are still required to translate cell and gene-modified cell therapy into effective and personalized clinical treatments for osteopetrosis.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OsteopetrosisGenetic TherapyCell- and Tissue-Based TherapyHumansAnimalsOsteoclastsInduced Pluripotent Stem CellsGenetic VectorsGene Therapy Agents

Stichwörter der Autor:innen

cell therapygene-modified cell therapyhematopoietic stem cell transplantationinduced pluripotent stem cellslentiviral vectorosteopetrosis

Autor:innen und Institutionen

  • Department of Biology and Human Genetics, Faculty of Medicine, University of Niš, Niš, Serbia.
  • Scientific research center for biomedicine, Faculty of Medicine, University of Niš, Niš, Serbia.

ORCID-Profile: Jelena G Najdanović

Förderung

  • Branch of SASA (Serbian Academy of Sciences and Arts) in Niš
  • Ministry of Education, Science and Technological Development of the Republic of Serbia

Zitieren

APA

Najdanović, J. G., Živković, J. M., & Najman, S. J. (2026). The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis. Human Gene Therapy, 37(13-14), 566-578. https://doi.org/10.1177/10430342261446500

Vancouver

Najdanović JG, Živković JM, Najman SJ. The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis. Human Gene Therapy. 2026;37(13-14):566-578. doi:10.1177/10430342261446500

BibTeX
@article{Najdanovi2026,
  author = {Najdanović, Jelena G and Živković, Jelena M and Najman, Stevo J},
  title = {The Application of Cell and Gene-Modified Cell Therapy in the Treatment of Osteopetrosis},
  journal = {Human Gene Therapy},
  year = {2026},
  volume = {37},
  number = {13-14},
  pages = {566--578},
  doi = {10.1177/10430342261446500}
}
Kostenlos starten →